Photo courtesy of Inovio.
Pentagon funds are helping Inovio develop and produce its Cellectra devices, which delivers its vaccine under a patient’s skin. Shown is the Cellectra 3PSP model.

Photo courtesy of Inovio. Pentagon funds are helping Inovio develop and produce its Cellectra devices, which delivers its vaccine under a patient’s skin. Shown is the Cellectra 3PSP model.

A company pursuing a DNA vaccine for COVID-19, Inovio Pharmaceuticals, received $71 million from the U...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99